DEVYSER DIAGNOSTICS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103 SEK | -1.90% |
|
+0.49% | +31.04% |
| Apr. 25 | Devyser Receives IVDR Approval for Post-Transplant Monitoring Software | CI |
| Mar. 11 | Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test | CI |
Quotes 5-day view
Delayed Quote Nasdaq Stockholm| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | 2024-04-29 | |
|---|---|---|---|---|---|
| Last | 104 kr | 102.5 kr | 103 kr | 105 kr | 103 kr |
| Volume | 12 234 | 455 | 4 243 | 2 387 | 4 057 |
| Change | +1.46% | -1.44% | +0.49% | +1.94% | -1.90% |
| Opening | 103.00 | 105.00 | 102.50 | 104.50 | 105 |
| High | 107.00 | 105.00 | 105.00 | 105.00 | 105 |
| Low | 103.00 | 102.50 | 102.00 | 103.50 | 102.5 |
Performance
| 1 day | +1.94% | ||
| 1 week | +0.96% | ||
| Current month | +3.45% | ||
| 1 month | +3.45% | ||
| 3 months | +17.98% | ||
| 6 months | +71.01% | ||
| Current year | +33.59% | ||
| 1 year | +21.53% |
Volumes
marketsDaily volume
2 387
Estimated daily volume
2 387
Avg. Volume 20 sessions
7 518
Daily volume ratio
0.32
Avg. Volume 20 sessions SEK
789 390.00
Avg. Volume 20 sessions USD
72 432.06
Record volume 1
480 953
Record volume 2
413 543
Record volume 3
256 893
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (SEK)
1 699 607 845
Capitalization (USD)
155 950 917
Net sales (SEK)
169 300 000
Net sales (USD)
15 534 460
Number of employees
118
Sales / Employee (SEK)
1 434 746
Sales / Employee (USD)
131 648
Free-Float
51.4 %
Free-Float capitalization (SEK)
873 637 251
Free-Float capitalization (USD)
80 162 333
Average Daily Capital Traded
0.05%
Highs and lows
1 week
102.00
107.00
1 month
100.00108.50
Current year
76.20109.00
1 year
57.40109.00
3 years
56.10109.00
5 years
56.10109.00
10 years
56.10109.00
Indicators
Moving average 5 days
103.40
Moving average 20 days
103.68
Moving average 50 days
96.62
Moving average 100 days
89.17
Price spread / (MMA5)
-1.52%
Price spread / (MMA20)
-1.26%
Price spread / (MMA50)
-7.98%
Price spread / (MMA100)
-15.08%
STIM
RSI 9 days
49.95
RSI 14 days
54.79
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.94% | +0.96% | +33.59% | +21.53% | 156M | ||
| +0.38% | +2.98% | +1.51% | +24.78% | 42.75B | ||
| +2.72% | +4.97% | +49.22% | -4.69% | 41.61B | ||
| +1.69% | +6.47% | +8.57% | -18.75% | 41.34B | ||
| -0.45% | +2.14% | -12.36% | +9.96% | 26.59B | ||
| +2.74% | +6.97% | +8.92% | +60.00% | 25.49B | ||
| -0.28% | -0.76% | -25.13% | -28.06% | 18.12B | ||
| +1.58% | +6.43% | +29.17% | +97.83% | 12.24B | ||
| +0.54% | +0.99% | -3.12% | +20.47% | 11.76B | ||
| -0.89% | -1.71% | +6.35% | +1.62% | 11B | ||
| +2.23% | +3.12% | -16.98% | -19.80% | 10.07B | ||
| +1.39% | +4.12% | -6.98% | -9.44% | 9.22B | ||
| +1.50% | +3.12% | +24.77% | -16.48% | 6.65B | ||
| +8.85% | +16.24% | +4.97% | -36.57% | 6.44B | ||
| +1.78% | +2.98% | +25.38% | +53.09% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +1.61% | +3.47% | +8.53% | +10.37% | ||
| Weighted average by Cap. | +1.38% | +3.69% | +8.99% | +9.38% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +33.59% | ||
| 2023 | +9.17% | ||
| 2022 | -18.74% | ||
| 2021 | -0.45% |
- Stock Market
- Equities
- DVYSR Stock
- Quotes Devyser Diagnostics AB
